Consolidation Therapy in Patients With Hematologic Malignancies
Status:
Not yet recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of Tumor Associated
Peptide Antigen (TAPA) pulsed dendritic cell (DC) vaccines in the treatment of hematologic
malignancies.